11 research outputs found
"What's (the) Matter?", A Show on Elementary Particle Physics with 28 Demonstration Experiments
We present the screenplay of a physics show on particle physics, by the
Physikshow of Bonn University. The show is addressed at non-physicists aged 14+
and communicates basic concepts of elementary particle physics including the
discovery of the Higgs boson in an entertaining fashion. It is also
demonstrates a successful outreach activity heavily relying on the university
physics students. This paper is addressed at anybody interested in particle
physics and/or show physics. This paper is also addressed at fellow physicists
working in outreach, maybe the experiments and our choice of simple
explanations will be helpful. Furthermore, we are very interested in related
activities elsewhere, in particular also demonstration experiments relevant to
particle physics, as often little of this work is published.
Our show involves 28 live demonstration experiments. These are presented in
an extensive appendix, including photos and technical details. The show is set
up as a quest, where 2 students from Bonn with the aid of a caretaker travel
back in time to understand the fundamental nature of matter. They visit
Rutherford and Geiger in Manchester around 1911, who recount their famous
experiment on the nucleus and show how particle detectors work. They travel
forward in time to meet Lawrence at Berkeley around 1950, teaching them about
the how and why of accelerators. Next, they visit Wu at DESY, Hamburg, around
1980, who explains the strong force. They end up in the LHC tunnel at CERN,
Geneva, Switzerland in 2012. Two experimentalists tell them about colliders and
our heroes watch live as the Higgs boson is produced and decays. The show was
presented in English at Oxford University and University College London, as
well as Padua University and ICTP Trieste. It was 1st performed in German at
the Deutsche Museum, Bonn (5/'14). The show has eleven speaking parts and
involves in total 20 people.Comment: 113 pages, 88 figures. An up to date version of the paper with high
resolution pictures can be found at
http://www.th.physik.uni-bonn.de/People/dreiner/Downloads/. In v2 the
acknowledgements and a citation are correcte
Individualized Mini-Panel Sequencing of ctDNA Allows Tumor Monitoring in Complex Karyotype Sarcomas
Soft tissue sarcomas (STS) are rare tumors of mesenchymal origin with high mortality. After curative resection, about one third of patients suffer from distant metastases. Tumor follow-up only covers a portion of recurrences and is associated with high cost and radiation burden. For metastasized STS, only limited inferences can be drawn from imaging data regarding therapy response. To date there are no established and evidence-based diagnostic biomarkers for STS due to their rarity and diversity. In a proof-of-concept study, circulating tumor DNA (ctDNA) was quantified in (n = 25) plasma samples obtained from (n = 3) patients with complex karyotype STS collected over three years. Genotyping of tumor tissue was performed by exome sequencing. Patient-individual mini-panels for targeted next-generation sequencing were designed encompassing up to 30 mutated regions of interest. Circulating free DNA (cfDNA) was purified from plasma and ctDNA quantified therein. ctDNA values were correlated with clinical parameters. ctDNA concentrations correlated with the tumor burden. In case of full remission, no ctDNA was detectable. Patients with a recurrence at a later stage showed low levels of ctDNA during clinical remission, indicating minimal residual disease. In active disease (primary tumor or metastatic disease), ctDNA was highly elevated. We observed direct response to treatment, with a ctDNA decline after tumor resections, radiotherapy, and chemotherapy. Quantification of ctDNA allows for the early detection of recurrence or metastases and can be used to monitor treatment response in STS. Therapeutic decisions can be made earlier, such as the continuation of a targeted adjuvant therapy or the implementation of extended imaging to detect recurrences. In metastatic disease, therapy can be adjusted promptly in case of no response. These advantages may lead to a survival benefit for patients in the future
"What's (the) Matter?", A Show on Elementary Particle Physics with 28 Demonstration Experiments
We present the screenplay of a physics show on particle physics, by the Physikshow of Bonn University. The show is addressed at non-physicists aged 14+ and communicates basic concepts of elementary particle physics including the discovery of the Higgs boson in an entertaining fashion. It is also demonstrates a successful outreach activity heavily relying on the university physics students. This paper is addressed at anybody interested in particle physics and/or show physics. This paper is also addressed at fellow physicists working in outreach, maybe the experiments and our choice of simple explanations will be helpful. Furthermore, we are very interested in related activities elsewhere, in particular also demonstration experiments relevant to particle physics, as often little of this work is published.
Our show involves 28 live demonstration experiments. These are presented in an extensive appendix, including photos and technical details. The show is set up as a quest, where 2 students from Bonn with the aid of a caretaker travel back in time to understand the fundamental nature of matter. They visit Rutherford and Geiger in Manchester around 1911, who recount their famous experiment on the nucleus and show how particle detectors work. They travel forward in time to meet Lawrence at Berkeley around 1950, teaching them about the how and why of accelerators. Next, they visit Wu at DESY, Hamburg, around 1980, who explains the strong force. They end up in the LHC tunnel at CERN, Geneva, Switzerland in 2012. Two experimentalists tell them about colliders and our heroes watch live as the Higgs boson is produced and decays. The show was presented in English at Oxford University and University College London, as well as Padua University and ICTP Trieste. It was 1st performed in German at the Deutsche Museum, Bonn (5/'14). The show has eleven speaking parts and involves in total 20 people
Usefulness of a Darwinian System in a Biotechnological Application: Evolution of Optical Window Fluorescent Protein Variants under Selective Pressure
ReSurveyEurope: A database of resurveyed vegetation plots in Europe
Aims: We introduce ReSurveyEurope - a new data source of resurveyed vegetation plots in Europe, compiled by a collaborative network of vegetation scientists. We describe the scope of this initiative, provide an overview of currently available data, governance, data contribution rules, and accessibility. In addition, we outline further steps, including potential research questions. Results: ReSurveyEurope includes resurveyed vegetation plots from all habitats. Version 1.0 of ReSurveyEurope contains 283,135 observations (i.e., individual surveys of each plot) from 79,190 plots sampled in 449 independent resurvey projects. Of these, 62,139 (78%) are permanent plots, that is, marked in situ, or located with GPS, which allow for high spatial accuracy in resurvey. The remaining 17,051 (22%) plots are from studies in which plots from the initial survey could not be exactly relocated. Four data sets, which together account for 28,470 (36%) plots, provide only presence/absence information on plant species, while the remaining 50,720 (64%) plots contain abundance information (e.g., percentage cover or cover-abundance classes such as variants of the Braun-Blanquet scale). The oldest plots were sampled in 1911 in the Swiss Alps, while most plots were sampled between 1950 and 2020. Conclusions: ReSurveyEurope is a new resource to address a wide range of research questions on fine-scale changes in European vegetation. The initiative is devoted to an inclusive and transparent governance and data usage approach, based on slightly adapted rules of the well-established European Vegetation Archive (EVA). ReSurvey:Europe data are ready for use, and proposals for analyses of the data set can be submitted at any time to the coordinators. Still, further data contributions are highly welcome